Verwandte Artikel zu Next Generation Antidepressants Hardback: Moving Beyond...
Next Generation Antidepressants Hardback: Moving Beyond Monoamines to Discover Novel Treatment Strategies for Mood Disorders (Cambridge Medicine (Hardcover)) - Hardcover
Inhaltsangabe
This 2010 book looks at the future of mood-disorder research, covering identification of new therapeutic targets, preclinical models, and medicinal chemistry opportunities, and increasing understanding of genetic influences. Essential reading for everyone involved in psychopharmacology development, and mental health clinicians seeking a preview of discoveries soon to influence their practice.
Die Inhaltsangabe kann sich auf eine andere Ausgabe dieses Titels beziehen.
Über die Autorinnen und Autoren
Chad E. Beyer is Prinicpal Research Scientist II at Pfizer Global Research and Development, Princeton, New Jersey and Adjunct Professor at Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
Stephen M. Stahl is Adjunct Professor of Psychiatry at the University of California San Diego, San Diego, California, and Neuroscience Education Institute, Carlsbad, California, USA.
„Über diesen Titel“ kann sich auf eine andere Ausgabe dieses Titels beziehen.
Neu kaufen
Diesen Artikel anzeigen
EUR 169,89
Gratis für den Versand innerhalb von/der Deutschland
Versandziele, Kosten & DauerSuchergebnisse für Next Generation Antidepressants Hardback: Moving Beyond...
Beispielbild für diese ISBN
Next Generation Antidepressants (Moving Beyond Monoamines to Discover Novel Treatment Strategies for Mood Disorders)
Verlag:
Cambridge University Press, 2010
ISBN 10: 0521760585
ISBN 13: 9780521760584
Gebraucht
Hardcover
Erstausgabe
Anbieter: Antiquariaat Die Sammlung, Amsterdam Zuidoost, Niederlande
Verkäuferbewertung 4 von 5 Sternen
Hardcover. Zustand: Fine. 1st Edition. 137 p. Artikel-Nr. BK 1-3 450
Anzahl: 1 verfügbar
Foto des Verkäufers
Next Generation Antidepressants
Anbieter: moluna, Greven, Deutschland
Verkäuferbewertung 5 von 5 Sternen
Gebunden. Zustand: New. This 2010 book looks at the future of mood-disorder research, covering identification of new therapeutic targets, preclinical models, and medicinal chemistry opportunities, and increasing understanding of genetic influences. Essential reading for everyone i. Artikel-Nr. 446946113
Anzahl: Mehr als 20 verfügbar
Foto des Verkäufers
Next Generation Antidepressants : Moving Beyond Monoamines to Discover Novel Treatment Strategies for Mood Disorders
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Verkäuferbewertung 5 von 5 Sternen
Buch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - The World Health Organization defines depression as a primary contributor to the global burden of disease and predicts it will become the second leading cause of death by 2020. The need to develop effective therapies has never been so pressing. Current antidepressant drugs have several limitations. This 2010 book looks at the future of mood-disorder research, covering the identification of new therapeutic targets, establishing new preclinical models, new medicinal chemistry opportunities, and fostering greater understanding of genetic influences. These strategies are likely to help build a better picture of the disease process, and lead to new opportunities for patient stratification and treatment. The ultimate goal for this strand of research is to develop more personalized and effective treatments for this chronic and debilitating condition. This is essential reading for all those involved in psychopharmacologic drug development, and mental health clinicians seeking a preview of discoveries soon to influence their practice. Artikel-Nr. 9780521760584
Anzahl: 1 verfügbar